Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp30 | Diabetes and Cardiovascular Disease | ECE2019

Cardiovascular risk factors in patients with type 2 diabetes and non-alcoholic fat liver disease

Svetlana Rodionova , Elena Birukova , Larisa Zvenigorodskaya

Background and aims: To investigate the level of lipoprotein associated phospholipase A2 (LpPLA2), nitrogen oxide (NO) in patients with type 2 diabetes (DM2) and nonalcoholic fatty liver disease (NAFLD) against a variety of hypoglycemic therapies (HT).Materials and methods: A one-stage examination of 90 patients with DM 2 and NAFLD was carried out. Men ratio 37.8%, women ratio 62.2%, mean age 57.3±11.6 years. Mean HbAlc 7.4±1.82%. According to ...

ea0063p143 | Diabetes, Obesity and Metabolism 1 | ECE2019

Clinical importance of determination of glytoxic methylglyoxal in nafld and type 2 type

Larisa Zvenigorodskaya , Michael Shinkin , Alexander Petrakov , Tamara Nilova

Introduction: The formation of oxidative stress in the biological reaction of inflammation is accompanied by the formation of methylglyoxal (MG), which initiates the glycosylation reaction of proteins. When hyperglycemia MG content significantly increased. MG interacts with the amino groups of lysine and arginine to form further glycation end products (CNG). Glycation is due to the ability of glucose to form irreversible chemical compounds of CNG with amino groups of proteins....

ea0063p145 | Diabetes, Obesity and Metabolism 1 | ECE2019

Retinol binding protein 4-marker insulin resistance in patients with diabetes mellitus 2 types and NAFLD

Larisa Zvenigorodskaya , Michael Shinkin , Tamara Nilova , Alexander Petrakov , Galina Varvanina

Introduction: Retinol binding protein (RSP) is a member of the adipokine family associated with insulin resistance (IR). With an excess of free fatty acids, the binding of insulin by hepatocyte receptors decreases and hyperinsulinemia develops. RSP is a transport protein for retinol, synthesized in hepatocytes and adipocytes. The level of RSP increased in patients with obesity, diabetes mellitus and non-alcoholic fatty liver disease (NAFLD) correlated positively with the sever...

ea0063p153 | Diabetes, Obesity and Metabolism 1 | ECE2019

Insulin content and activity of inflammatory markers in patients with nonalcoholic fatial liver disease and diabetes of the second type

Larisa Zvenigorodskaya , Mikhail Shinkin , Tamara Nilova , Galina Varvanina , Alexander Petrakov

Pathogenesis of Non-alcoholic fatty liver disease in 90% combined with diabetes mellitus (DM) of the second type. Factors cutting: abdominal obesity, excessive content of free fatty acids. Development of insulin resistance through protein kinase. Violation of the transmission of insulin signal leads to damage to the endothelium. Glycation of nitric oxide synthase leads to the development of diabetic complications and violates the sensitivity of the insulin receptors.<p cla...

ea0063p606 | Diabetes, Obesity and Metabolism 2 | ECE2019

Complex use of noninvasive methods for estimating microcirculation of the blood and oxidative metabolism on the big sting finger in patients with diabetes, such as permeable diagnostic diagnostics diagnostics, patients with diable diagnosis

Mikhail 6/5000 Michael Shinkin , Ashot Mktrumyan , Larisa Zvenigorodskaya

Purpose of the study: Assess the criteria for early diagnosis of the risk of developing diabetic foot syndrome as a microvasculature using laser Doppler flowmetry and tissue metabolism using fluorescence spectroscopy in diabetic patients.Materials and methods: The studies are carried out with the help of the Laser Diagnostic LASMA ST Apparatus ‘(OOO NPP’ LAZMA’, Moscow) on the plantar surface of the big toe in three stages: resting state -...